ROIV- Roivant Sciences Ltd.

Name: Roivant Sciences Ltd. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 14 buys and 3 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Roivant Sciences Ltd.	113.32M	$3.54B	-
10%	Ramaswamy Vivek	33.65M	$1.05B	-
Pres	Sukhatme Mayukh	18.68M	$583.68M	-
CEO	Gline Matthew	16.74M	$523.00M	-
Dir	Gold Daniel Allen	15.35M	$479.76M	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2022	Gline Matthew	CEO	Sell	92,324	$5.52	$509,628.48	-5.5%	-26.2%	+51.9%
Sep 4, 2020	Roivant Sciences Ltd.78	10% Owner	Buy	380,000	$33.00	$12,540,000.00	+0.8%	-	-
Apr 16, 2020	Roivant Sciences Ltd.78	10% Owner	Buy	1,034,483	$14.50	$15,000,003.50	+2.8%	-	-
Feb 24, 2020	Roivant Sciences Ltd.78	10% Owner	Buy	5,333,333	$3.75	$19,999,998.75	+40.3%	-	-
Dec 27, 2019	Roivant Sciences Ltd.78	10% Owner	Sell	22,860,013	$0.00	-	-100%	-	-
Dec 27, 2019	Roivant Sciences Ltd.78	10% Owner	Sell	45,008,604	$0.00	-	-100%	-	-
Dec 17, 2019	Roivant Sciences Ltd.78	10% Owner	Buy	245,000	$15.38	$3,767,705.89	+0.2%	-	-
Dec 4, 2019	Roivant Sciences Ltd.78	10% Owner	Buy	254,193	$18.03	$4,584,355.61	+0.1%	-	-
Nov 25, 2019	Roivant Sciences Ltd.78	10% Owner	Buy	3,500,000	$15.00	$52,500,000.00	+8.5%	-	-
Nov 21, 2019	Roivant Sciences Ltd.78	10% Owner	Buy	243,812	$12.39	$3,021,688.14	+0.2%	-	-

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC